These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30430290)

  • 1. Methods to handle missing values and missing individuals.
    Bonander C; Strömberg U
    Eur J Epidemiol; 2019 Jan; 34(1):5-7. PubMed ID: 30430290
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study.
    Park HE; Kwak MS; Kim D; Kim MK; Cha MJ; Choi SY
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3134-43. PubMed ID: 27253666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Gu S; Kim H; Seong D; Cho SJ; Yi BK; Park HD; Paik SW; Song YB; Lazo M; Lima JA; Guallar E; Cho J; Gwak GY
    Gut; 2017 Feb; 66(2):323-329. PubMed ID: 27599521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the relationship between non-alcoholic fatty liver disease and coronary artery disease.
    Topuz M; Dogan A; Celik A; Can C; Ozdogru I; Kemal Eryol N
    Clin Ter; 2014; 165(1):e46-51. PubMed ID: 24589960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk estimation in non alcoholic fatty liver disease.
    Romdhane H; Cheikh M; Ennaifer R; Mahmoud Y; Bougassas W; Ben Nejma H; Bel Hadj N
    Tunis Med; 2016 Dec; 94(12):839. PubMed ID: 28994882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of fatty liver by computed tomography coronary artery calcium score.
    Kerut SE; Balart JT; Kerut EK; McMullan MR
    Echocardiography; 2017 Jun; 34(6):937-938. PubMed ID: 28493399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Yip GW; Lo AO; Limquiaco J; Chu WC; Chim AM; Yu CM; Yu J; Chan FK; Sung JJ; Chan HL
    Gut; 2011 Dec; 60(12):1721-7. PubMed ID: 21602530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification.
    You SC; Kim KJ; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1536-42. PubMed ID: 25973647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Odds Ratios-Current Best Practice and Use.
    Norton EC; Dowd BE; Maciejewski ML
    JAMA; 2018 Jul; 320(1):84-85. PubMed ID: 29971384
    [No Abstract]   [Full Text] [Related]  

  • 10. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.
    Puchner SB; Lu MT; Mayrhofer T; Liu T; Pursnani A; Ghoshhajra BB; Truong QA; Wiviott SD; Fleg JL; Hoffmann U; Ferencik M
    Radiology; 2015 Mar; 274(3):693-701. PubMed ID: 25369449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.
    Miyake T; Kumagi T; Hirooka M; Furukawa S; Yoshida O; Koizumi M; Yamamoto S; Watanabe T; Yamamoto Y; Tokumoto Y; Takeshita E; Abe M; Kitai K; Matsuura B; Hiasa Y
    J Gastroenterol; 2016 Nov; 51(11):1090-1100. PubMed ID: 26971094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study.
    Kim BJ; Cheong ES; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(3):619-626.e1. PubMed ID: 27206950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
    Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.
    Sinn DH; Gwak GY; Cho J; Son HJ; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Atherosclerosis; 2014 Jun; 234(2):270-5. PubMed ID: 24704629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
    Jacobs K; Brouha S; Bettencourt R; Barrett-Connor E; Sirlin C; Loomba R
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1337-1344.e3. PubMed ID: 26820400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imputation of missing values in the case of a multiple item instrument measuring alcohol consumption.
    Gmel G
    Stat Med; 2001 Aug; 20(15):2369-81. PubMed ID: 11468769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    Yang YJ; Bang CS; Shin SP; Baik GH
    PLoS One; 2017; 12(8):e0182014. PubMed ID: 28777831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.
    Jaruvongvanich V; Wirunsawanya K; Sanguankeo A; Upala S
    Dig Liver Dis; 2016 Dec; 48(12):1410-1417. PubMed ID: 27697419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.
    Kim GH; Chung JW; Lee JH; Ok KS; Jang ES; Kim J; Shin CM; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH; Kim JW
    Clin Mol Hepatol; 2015 Dec; 21(4):379-86. PubMed ID: 26770927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.